skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

22 Total results for product and free and sample content found


Maximize your drugs market potential in a payer dominated world

17 Aug 2017

See how the value of drugs differentiate therapies by sub-population. Find out where the disproportionate value of your drug lies alongside competitors. Uncover demonstrable differentiated value when entering a crowded market. Discover the power of RxScorecard™.

Topic Reimbursement

Pink Sheet

Biogen Ventures Into Value-Based Contracts In Multiple Sclerosis

By Cathy Kelly 10 Aug 2017

Four contracts test approaches tying reimbursement to relapse rates and discontinuation of treatment.

Topic Reimbursement

Datamonitor Healthcare

Reimbursement Challenges in the US and Europe

By Tijana Ignjatovik 09 Jun 2017

Informa's Japanese office, a British company that operates Pharma Intelligence, held a special free seminar in Tokyo on May 17, 2017.

Topic Reimbursement

Datamonitor Healthcare

Inside the payer perspective market

08 Jun 2017

Market Access & Reimbursement: Inside the Payer Perspective on Multiple Myeloma

Topic Reimbursement

Pink Sheet

Abuse-Deterrent Opioids: ICER Value Analysis Could Reinforce Coverage Restrictions

By Cathy Kelly 12 May 2017

Draft report concludes that added cost of abuse-deterrent opioids is not outweighed by reductions to health care system costs resulting from their use.

Topic Reimbursement


BioMarin Expects 30% Markdown For Orphan Pediatric Drug Brineura

By Emily Hayes 02 May 2017

Fast US approval of ultra-rare pediatric disease drug Brineura (cerliponase alfa), with an annual list price of $702,000, is a victory for the company, but approval for restricted pediatric population compared to Europe raised questions.

Topic Rare Disease Reimbursement

Medtech Insight

Philips' eICU Telemedicine Program Yields Cost Savings, Slows Readmissions For Emory

18 Apr 2017

Five Emory University-affiliated hospitals taking part in a Philips eICU program cut total costs by $4.6m – or $1,468 per average care episode – reduced discharges to nursing homes by 6.9%, and lowered inpatient readmission rates, according to a recent audit by CMS contractors.

Topic Reimbursement

Pink Sheet

Samsung Bioepis’s Biosimilar Enbrel ‘Substitutable’ In Australia As Pfizer Patent Case Is Rebuffed

By Ian Schofield 12 Apr 2017

Samsung Bioepis’s Brenzys has become the second biosimilar product to be reimbursed as substitutable at the pharmacy level in Australia.

Topic Reimbursement

Pink Sheet

Drug Price Controls As Part Of The Repertoire

By Cathy Kelly 21 Mar 2017

President's pledge to merge drug pricing control with a revamp of the Affordable Care Act wins applause at Kentucky rally, where the president reeled through a number of his populist issues, even as the idea makes scant legislative progress.

Topic Policy and regulation Reimbursement

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907
  • Japan            : +81 3-6273-4257

Or email us your inquiry, so we can provide you the best possible customer service:

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: